Analysts expect BridgeBio Pharma, Inc. to report revenue of 261.80 M for Q3 26, against a range of 237.48 M to 286.11 M. The most recent reported quarter, Q2 26, came in at 243.68 M, a 5.8% beat against the 230.26 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 2.73 M | 5.88 M | 116.63 M | 110.56 M | 120.70 M | 154.18 M | 194.51 M | 243.68 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 1.66 M | 3.07 M | 65.53 M | 89.46 M | 109.01 M | 151.50 M | 192.41 M | 247.50 M | 286.11 M | 349.79 M | 366.82 M | 378.48 M | 840.34 M | 1.29 B | 627.57 M | 367.10 M | ||||||||||
| Low Estimate | 1.54 M | 2.77 M | 60.99 M | 82.17 M | 97.93 M | 134.17 M | 172.25 M | 213.01 M | 237.48 M | 323.35 M | 327.55 M | 350.37 M | 733.53 M | 1.10 B | 541.09 M | 332.51 M | ||||||||||
| Consensus Estimate | 1.60 M | 2.92 M | 63.26 M | 85.81 M | 103.47 M | 142.83 M | 182.33 M | 230.26 M | 261.80 M | 336.57 M | 347.18 M | 364.43 M | 786.94 M | 1.20 B | 584.33 M | 349.81 M |
Analysts expect BridgeBio Pharma, Inc. to report earnings per share of -0.63 for Q3 26, against a range of -0.66 to -0.60. The most recent reported quarter, Q2 26, came in at -0.78, a 30.0% miss against the -0.60 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.86 | -1.40 | -0.88 | -0.95 | -0.95 | -1.00 | -0.84 | -0.78 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.91 | -1.12 | -0.78 | -0.69 | -0.81 | -0.64 | -0.67 | -0.55 | -0.60 | -0.42 | -0.23 | -0.16 | -0.09 | 0.03 | 0.80 | 0.93 | ||||||||||
| Low Estimate | -0.99 | -1.26 | -0.94 | -0.79 | -0.89 | -0.70 | -0.75 | -0.65 | -0.66 | -0.48 | -0.27 | -0.18 | -0.11 | 0.03 | 0.74 | 0.83 | ||||||||||
| Consensus Estimate | -0.95 | -1.19 | -0.86 | -0.74 | -0.85 | -0.67 | -0.71 | -0.60 | -0.63 | -0.45 | -0.25 | -0.17 | -0.10 | 0.03 | 0.77 | 0.88 |
Pull Wall Street consensus for BridgeBio Pharma, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=BBIO&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "BBIO", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=BBIO&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();